InvestorsHub Logo
Followers 230
Posts 15196
Boards Moderated 0
Alias Born 03/30/2005

Re: olden_grumpini post# 317949

Sunday, 08/09/2020 12:00:21 PM

Sunday, August 09, 2020 12:00:21 PM

Post# of 403568
I agree. I think others have expressed that same feeling. This isn't a brilacidin specific study, however we will have in vitro results from the RBL on many different levels we can use to proceed into human trials. Raising money here was an issue prior to covid 19. There are dozens of pubco's now that were trading under $1 in February that are now $5, $10, $20 and higher (vaccines, diagnostics, ppe, therapeutics).

With liquidity back, hence the $6 million cash in the bank announcement as of June 30th, IPIX should be doing whatever they can to get into human trials asap and not brag that they got amazing research for $35,000. I keep flip flopping my sentiment. Ultimately I think our IND gets approved for human trials, but we aren't there yet frown

And if we are part of a larger research project with scores of other therapeutics and/or vaccines, hopefully we top the list across the board propelling us into the stratosphere.

the above is all IMHO (consider this my safe harbor statement)